# Tel Aviv Sourasky Medical Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/tel-aviv-sourasky-medical-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 49 |
| Citations | 2,046,065 |
| City | Tel Aviv |
| Country | IL |
| Description | Tel Aviv Sourasky Medical Center is a research organisation in Tel Aviv, IL. OpenAlex records 22,645 works and 2,046,065 citations for it. 6,350 researchers list it as their most recent affiliation. |
| Homepage | http://www.tasmc.org.il/sites/en/Pages/default.aspx |
| OpenAlex ID | https://openalex.org/I2799807261 |
| Researchers | 6,350 |
| ROR ID | https://ror.org/04nd58p63 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q2561450 |
| Works | 22,645 |

## University papers

- [International evidence-based recommendations for point-of-care lung ultrasound](https://scholariq.org/papers/international-evidence-based-recommendations-for-point-of-care-lung-ultrasound/)
- [Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-in-combination-with-gemcitabine-and-cisplatin-compared-with/)
- [Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort](https://scholariq.org/papers/antitumor-activity-of-pembrolizumab-in-biomarker-unselected-patients-with/)
- [American College of Chest Physicians/La Société de Réanimation de Langue Française Statement on Competence in Critical Care Ultrasonography](https://scholariq.org/papers/american-college-of-chest-physicians-la-societe-de-reanimation-de-langue/)
- [Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-with-cisplatin-and-fluoropyrimidine-as-first-line-therapy-in/)
- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)
- [Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma](https://scholariq.org/papers/prophylactic-corticosteroid-use-in-patients-receiving-axicabtagene-ciloleucel/)

## University top topics

Showing 8 of 25.

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Balance, Gait, and Falls Prevention](https://scholariq.org/topics/balance-gait-and-falls-prevention/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Pregnancy and preeclampsia studies](https://scholariq.org/topics/pregnancy-and-preeclampsia-studies/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.